https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Gene therapy and type 1 diabetes mellitus https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33590 Wed 15 Dec 2021 16:08:03 AEDT ]]> Young people with type 1 diabetes mellitus: attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30976 Wed 06 Apr 2022 14:00:21 AEST ]]> Healthy weight and overweight adolescents with type 1 diabetes mellitus do not meet recommendations for daily physical activity and sleep https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54313 Tue 20 Feb 2024 14:29:22 AEDT ]]> Screening practices for disordered eating in paediatric type 1 diabetes clinics https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39347 20%, while eight reported rates < 5%. All clinics used the routine clinical interview as the primary method of screening for disordered eating. Only one used screening tools; these were not diabetes-specific or routinely used. Barriers to use of screening tools included shortage of time and lack of staff confidence around use (n = 7, 70%). Enablers included staff training in disordered eating. Conclusions: Screening tools for disordered eating are not utilised by most Australasian paediatric T1D clinics. Overall, low reported rates of disordered eating suggest that it may be undetected, potentially missing an opportunity for early intervention.]]> Thu 28 Jul 2022 15:20:44 AEST ]]> Effect of popular takeaway foods on blood glucose levels in type 1 diabetes mellitus patients on intensive insulin therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8399 Sat 24 Mar 2018 08:40:59 AEDT ]]> Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7972 12 yr, HbA1c is lower while using ezy-BICC than CSII. HbA1c increases 0.2% per yr following diagnosis for 2.8 yr. In those who change from mixed insulin to ezy-BICC after this time, the mean HbA1c is 0.5% lower by 9 months, 0.7% lower at 21 months and 0.6% lower at 24 months (p < 0.05). Conclusions: The ezy-BICC system is inexpensive and convenient and allows patients to vary meal size. Subjects achieve lower HbA1c while using CSII and ezy-BICC MDI than with mixed insulin. Very young subjects achieve excellent HbA1c using CSII, but for 12 to 20 yr-old patients, ezy-BICC results in lower HbA1c than CSII for a lower cost.]]> Sat 24 Mar 2018 08:33:40 AEDT ]]> A systematic stochastic design strategy achieving an optimal tradeoff between peak BGL and probability of hypoglycaemic events for individuals having type 1 diabetes mellitus https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36297 Mon 15 Apr 2024 10:40:44 AEST ]]> A systematic review of patient-reported outcome measures in paediatric endocrinology https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43028 Mon 12 Sep 2022 11:14:32 AEST ]]>